NAPROXEN\PSEUDOEPHEDRINE: 383 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
383
Total FAERS Reports
2 (0.5%)
Deaths Reported
4
Hospitalizations
383
As Primary/Secondary Suspect
2
Life-Threatening
2
Disabilities
Active Ingredient: NAPROXEN SODIUM\PSEUDOEPHEDRINE HYDROCHLORIDE ·
First Report: 2007 · Latest Report: 20250201
What Are the Most Common NAPROXEN\PSEUDOEPHEDRINE Side Effects?
#1 Most Reported
Drug ineffective
119 reports (31.1%)
#2 Most Reported
Off label use
42 reports (11.0%)
#3 Most Reported
Incorrect dose administered
34 reports (8.9%)
All NAPROXEN\PSEUDOEPHEDRINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 119 | 31.1% | 0 | 0 |
| Off label use | 42 | 11.0% | 1 | 1 |
| Incorrect dose administered | 34 | 8.9% | 0 | 0 |
| Drug effective for unapproved indication | 28 | 7.3% | 0 | 0 |
| Insomnia | 28 | 7.3% | 0 | 0 |
| Expired product administered | 17 | 4.4% | 0 | 0 |
| Therapeutic response unexpected | 15 | 3.9% | 0 | 0 |
| Wrong technique in product usage process | 15 | 3.9% | 0 | 0 |
| Dizziness | 13 | 3.4% | 0 | 0 |
| Feeling abnormal | 13 | 3.4% | 0 | 0 |
| Incorrect drug administration duration | 12 | 3.1% | 0 | 0 |
| Drug effect incomplete | 8 | 2.1% | 0 | 0 |
| Heart rate increased | 8 | 2.1% | 0 | 0 |
| Inappropriate schedule of product administration | 8 | 2.1% | 0 | 0 |
| Incorrect product administration duration | 8 | 2.1% | 0 | 0 |
| Nausea | 8 | 2.1% | 0 | 0 |
| Drug ineffective for unapproved indication | 7 | 1.8% | 0 | 0 |
| No adverse event | 7 | 1.8% | 0 | 0 |
| Pruritus | 7 | 1.8% | 1 | 1 |
| Abdominal pain upper | 6 | 1.6% | 0 | 0 |
Who Reports NAPROXEN\PSEUDOEPHEDRINE Side Effects? Age & Gender Data
Gender: 70.3% female, 29.7% male. Average age: 51.5 years. Most reports from: US. View detailed demographics →
Is NAPROXEN\PSEUDOEPHEDRINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2007 | 2 | 0 | 0 |
| 2011 | 3 | 0 | 0 |
| 2012 | 3 | 0 | 0 |
| 2013 | 2 | 0 | 0 |
| 2014 | 1 | 0 | 0 |
| 2015 | 49 | 0 | 0 |
| 2016 | 57 | 0 | 0 |
| 2017 | 47 | 0 | 0 |
| 2018 | 42 | 0 | 0 |
| 2019 | 46 | 0 | 0 |
| 2020 | 15 | 0 | 0 |
| 2021 | 17 | 0 | 0 |
| 2022 | 20 | 0 | 0 |
| 2023 | 14 | 0 | 1 |
| 2024 | 10 | 0 | 0 |
| 2025 | 1 | 0 | 0 |
What Is NAPROXEN\PSEUDOEPHEDRINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 95 |
| Hypersensitivity | 60 |
| Nasopharyngitis | 52 |
| Sinus headache | 44 |
| Headache | 41 |
| Sinus congestion | 35 |
| Viral upper respiratory tract infection | 35 |
| Paranasal sinus discomfort | 34 |
| Nasal congestion | 29 |
| Sinus disorder | 16 |
NAPROXEN\PSEUDOEPHEDRINE vs Alternatives: Which Is Safer?
NAPROXEN\PSEUDOEPHEDRINE vs NAPROXEN\SUMATRIPTAN
NAPROXEN\PSEUDOEPHEDRINE vs NARATRIPTAN
NAPROXEN\PSEUDOEPHEDRINE vs NASONEX
NAPROXEN\PSEUDOEPHEDRINE vs NATALIZUMAB
NAPROXEN\PSEUDOEPHEDRINE vs NATALIZUMAB-SZTN
NAPROXEN\PSEUDOEPHEDRINE vs NATAMYCIN
NAPROXEN\PSEUDOEPHEDRINE vs NATEGLINIDE
NAPROXEN\PSEUDOEPHEDRINE vs NAVITOCLAX
NAPROXEN\PSEUDOEPHEDRINE vs NAXITAMAB-GQGK
NAPROXEN\PSEUDOEPHEDRINE vs NEBIVOLOL
Official FDA Label for NAPROXEN\PSEUDOEPHEDRINE
Official prescribing information from the FDA-approved drug label.